Emory research close to vaccine for RSV
There may soon be a vaccine for Respiratory Syncytial Virus Infection (RSV). In children younger than a year RSV is the most common cause of bronchiolitis, an inflammation of the small airways in the lung, and pneumonia, an infection of the lungs.
Children's Healthcare of Atlanta is reporting a nearly 25 percent increase in RSV cases over this time last year. Emory researcher, Martin Moore says RSV blocks the airways and causes respiratory failure. Dr. Moore is also a faculty member in the IMP and MMG programs.
The struggle with creating a vaccine against RSV is trying to make a vaccine that's safe and potent. Moore says he thinks they are close to doing just that and he hopes his vaccine will go into clinical trials within a year.